PUBLISHER: The Business Research Company | PRODUCT CODE: 1945277
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945277
Hematology analyzers perform complete blood counts with white blood cell differentials, detect abnormal cell populations, and assess cell morphology to help diagnose various blood disorders.
The primary products in hematology analyzers and reagents include hematology analyzers, hemostasis analyzers, plasma protein analyzers, hemoglobin analyzers, erythrocyte sedimentation rate analyzers, coagulation analyzers, flow cytometers, slide stainers, differential counters, and hematology stains. Hematology analyzers are instruments used to determine hemoglobin concentration in blood samples. The applications include anemia, blood cancers, hemorrhagic disorders, infection-related conditions, immune system-related diseases, and others, and they are used by end users such as specialized research institutes, hospitals, advanced diagnostic centers, and others.
Tariffs are impacting the hematology analyzers and reagents market by increasing costs for imported analyzers, electronic components, and specialized reagents used in diagnostic testing. Segments such as automated hematology analyzers, flow cytometers, and coagulation analyzers are most affected, particularly in Asia-Pacific and emerging regions that depend on imported diagnostic equipment. These cost pressures have led to higher pricing and delayed procurement for hospitals and laboratories. However, tariffs have also encouraged local manufacturing, reagent localization, and partnerships to reduce dependency on imports and strengthen regional diagnostic capabilities.
The hematology analyzers and reagents market research report is one of a series of new reports from The Business Research Company that provides hematology analyzers and reagents market statistics, including hematology analyzers and reagents industry global market size, regional shares, competitors with a hematology analyzers and reagents market share, detailed hematology analyzers and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the hematology analyzers and reagents industry. This hematology analyzers and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hematology analyzers and reagents market size has grown marginally in recent years. It will grow from $5.25 billion in 2025 to $5.26 billion in 2026 at a compound annual growth rate (CAGR) of 0.2%. The growth in the historic period can be attributed to increasing prevalence of anemia and blood-related disorders, growing hospital and diagnostic laboratory infrastructure, reliance on manual and semi-automated analyzers, rising demand for complete blood count testing, expansion of clinical diagnostic services.
The hematology analyzers and reagents market size is expected to see strong growth in the next few years. It will grow to $7.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to integration of AI-based cell analysis, rising adoption of fully automated hematology systems, growing focus on precision medicine and personalized diagnostics, expansion of diagnostic centers in emerging markets, increasing demand for advanced reagents and consumables. Major trends in the forecast period include rising adoption of automated and high-throughput hematology analyzers, growing demand for accurate and early diagnosis of blood disorders, increasing use of point-of-care hematology testing, expansion of reagent rental and consumable-based business models, enhanced focus on standardization and quality control in hematology testing.
The rise in the prevalence of blood disorders is increasingly supporting the expansion of the hematology analyzers and reagents market going forward. Blood disorders are medical conditions that impair the normal function of blood components such as red blood cells, white blood cells, or platelets. Hematology analyzers and reagents are essential for diagnosing and monitoring blood disorders, including blood cancers, by evaluating blood cell counts, morphology, and related parameters. For example, in July 2024, according to Cancer Research UK, a UK-based charity, the average annual number of new Hodgkin lymphoma cases in the UK is projected to increase from approximately 2,400 cases during 2023-2025 to around 2,900 cases during 2038-2040. Consequently, the growing prevalence of blood disorders is supporting the expansion of the hematology analyzers and reagents market.
Leading companies operating in the hematology analyzers and reagents market are focusing on developing innovative solutions, such as automated hematology platforms, to improve diagnostic accuracy, streamline laboratory workflows, and deliver more comprehensive patient data. An automated hematology platform is a computer-driven laboratory system designed to perform complete blood counts and related tests quickly and accurately with minimal human involvement. For example, in January 2024, HORIBA Medical, a France-based in vitro diagnostics company, launched Yumizen Helo, a next-generation, fully automated and modular hematology solution. The system integrates a high-throughput analyzer, digital cell morphology, and automated reticulocyte analysis into a single compact unit. Its walkaway automation uses an intelligent robotic arm to prepare and sort blood smears automatically, reducing manual steps and improving productivity by consolidating multiple hematology tasks into one continuous workflow.
In January 2024, Fujirebio Holdings, a Japan-based diagnostics company, entered into a partnership with Agappe Diagnostics Ltd. Through this partnership, the companies aim to collaborate on the development of advanced diagnostic technologies and expand their product offerings within the global healthcare market. Agappe Diagnostics Ltd. is an India-based diagnostics company specializing in the development and manufacture of a wide range of innovative diagnostic solutions.
Major companies operating in the hematology analyzers and reagents market are Abbott Laboratories, Bio-Rad Laboratories, Horiba Ltd., Siemens AG, Sysmex Corporation, BioSystems Diagnostics Pvt. Ltd, Boule Diagnostics, Danaher Corporation, Diatron MI PLC, Drew Scientific, EKF Diagnostics, Mindray, Nihon Kohden, Ortho Clinical Diagnostics, Roche, Beckman Coulter, Bayer AG, Heska, Drucker, Instrumentation Laboratory, Abaxis Inc., Accriva Diagnostics, ACON, Diamond Diagnostics, ERBA Diagnostics, Hycel, Maccura Biotechnology Co. Ltd., Genrui Biotech Inc., A&T Corporation, Beijing Succeeder Technology Inc., Diagnostica Stago SAS
North America was the largest region in the hematology analyzers and reagents market in 2025. Western Europe was the second-largest region in the hematology analyzers and reagents market report. The regions covered in the hematology analyzers and reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hematology analyzers and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hematology analyzers and reagents market consists of sales electrolyte analyzers, hemocoagulometer, enzyme standard instruments, blood gas analyzers and immunoturbidimetry. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hematology Analyzers and Reagents Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses hematology analyzers and reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hematology analyzers and reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hematology analyzers and reagents market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.